John L. Slebir - Feb 18, 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
SVP General Counsel
Signature
John L. Slebir, by /s/ Trevor Dutcher, Attorney-in-Fact
Stock symbol
DVAX
Transactions as of
Feb 18, 2025
Transactions value $
-$69,279
Form type
4
Date filed
2/21/2025, 04:39 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +16.7K +66.5% 41.7K Feb 18, 2025 Direct F1
transaction DVAX Common Stock Tax liability -$69.3K -5.36K -12.84% $12.93 36.4K Feb 18, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -16.7K -33.33% 33.3K Feb 18, 2025 Common Stock 16.7K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
F2 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.